Home › Sakit ni Parkinson › Michigan
Pag-aaral pangklinika para sa Sakit ni Parkinson sa Michigan
22 pag-aaral para sa Sakit ni Parkinson ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-015, Farmington Hills
Nagre-recruitPhase 2/3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06976268Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Michigan, Ann Arbor
- Michigan State University, East Lansing
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07005180A Study of Buntanetap in Participants With PD
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 2/3
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Michigan Health System (UMHS) (Site #202), Ann Arbor
- Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
Nagre-recruitPhase 2
Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07432958A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07514858A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Michigan, Ann Arbor
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07174310A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Quest Research Institute - Alcanza, Farmington Hills
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06565195A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06680830A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Domino's Farms, Ann Arbor
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07543861A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Michigan Clinical Research Unit - Neurology, Ann Arbor
- University of Michigan Clinical Research Unit - Neurology, Ann Arbor
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 3
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Michigan, Ann Arbor
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04477785A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Michigan State University (Neurology), East Lansing
- Quest Research Institute (Neurology), Farmington Hills
Nagre-recruitPhase 2
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06285643Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- University of Michigan, Ann Arbor
Nagre-recruitObservasyonal na pag-aaral
Edad 45 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT07642908Natural History Study of Synucleinopathies
- University of Michigan, Ann Arbor
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT01799915SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 1
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT07422675Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- Michigan State University, East Lansing
Nagre-recruit
Edad 50 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT07599696A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- QUEST Research Institute, Farmington Hills
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 85 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06809400Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- University of Michigan, Ann Arbor
Nagre-recruitPhase 2
Edad 45 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT06679374Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Domino's Farms, Ann Arbor
Nagre-recruitPhase 1/2
Edad 45 pataas · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT07154511A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2025 · NCT06765668Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.